Journal
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publication Date
1-1-2026
Volume
18
Issue
2
First Page
e70325
Document Type
Open Access Publication
DOI
10.1002/dad2.70325
Rights and Permissions
Luckett PH, Petersen M, O'Bryant S, et al. Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndrome. Alzheimer's Dement. 2026; 18:e70325. https://doi.org/10.1002/dad2.70325 © 2026 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Recommended Citation
Luckett, Patrick H; Petersen, Melissa; O'Bryant, Sid; Mapstone, Mark; Christian, Brad T; Handen, Benjamin; Head, Elizabeth; Ances, Beau M; and Alzheimer's Biomarker Consortium‐Down Syndrome, "Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndrome." Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 18, 2. e70325 (2026).
https://digitalcommons.wustl.edu/oa_4/7206
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
